Researcher at Mercy University Hospital Targets Inflammatory Bowel Disease (P615 Clinical efficacy of accelerated 4-weekly vs. Conventional 8-weekly ustekinumab dosing in Inflammatory Bowel Disease: A single centre experience)

Press/Media

Period12 Feb 2024

Media coverage

1

Media coverage

  • TitleResearcher at Mercy University Hospital Targets Inflammatory Bowel Disease (P615 Clinical efficacy of accelerated 4-weekly vs. Conventional 8-weekly ustekinumab dosing in Inflammatory Bowel Disease: A single centre experience)
    Media name/outletImmunotherapy Daily
    Country/TerritoryUnited States
    Date12/02/24
    PersonsMarietta Iacucci
View all 1
View less